Pacibekitug

DB19307InvestigationalProtein Based Therapies

Human anti-il-6 monoclonal antibody (pf-04236921) is under investigation in clinical trial NCT01405196 (Subcutaneous Treatment in Randomized Subjects to Evaluate Safety and Efficacy in Generalized Lupus Erythematosus).

Mechanism: Pharmacologically active on Interleukin-6
Curator reviewed
Also known as: HUMAN ANTI-IL-6 MONOCLONAL ANTIBODY (PF-04236921)
Code names: PAC-001 · PF-04236921 · PF-4236921 · TOUR006

Resolves to

Compound

UNII2NHW9AKY9CCAS1822383-06-1

Targets

P05231IL6

What you can answer from here — as of April 27, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Pacibekitug, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account